pharma · Diabetic Macular Edema · Non-infectious Uveitis Affecting the Posterior Segment of the Eye · ANIP
ANI PHARMACEUTICALS
ANI PHARMACEUTICALS INC
ANI Pharmaceuticals is a pharma organization headquartered in Princeton, USA. It trades on NYSE under ticker ANIP. Primary therapeutic focus areas include Diabetic Macular Edema, Non-infectious Uveitis Affecting the Post
500 Alexander Park, Princeton, New Jersey 08540, US HQ
678 Employees
Public company Type
ANIP · NYSE Ticker
Company details
- Status
- Public
- HQ
- 500 Alexander Park, Princeton, New Jersey 08540, US
- Employees
- 678
- Programs
- 11
- Drugs
- 7
- Patents
- 7
ILUVIEN 0.19 MG
Approved · small molecule · Diabetic Macular Edema (DME)
ILUVIEN 0.19 MG for Diabetic Macular Edema (DME) is a Approved program (small_molecule) at ANI PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Internal code M-01-15-004
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ANI PHARMACEUTICALS INC
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Diabetic Macular Edema (DME)
- Status
- completed
- Trials
- 1